I-Brom Plus Ophthalmic Solution

Bromfenac exerts its effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and edema. Moxifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication, leading to bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens.

The combined use of Bromfenac and Moxifloxacin in I-Brom Plus Ophthalmic Solution provides both anti-inflammatory and antimicrobial effects, facilitating improved patient outcomes by minimizing postoperative inflammation and preventing secondary infections. The solution is typically administered as eye drops, with dosing frequency and duration determined by the prescribing ophthalmologist based on the severity of the condition.

Patients should be advised to avoid contamination of the dropper tip and adhere strictly to the prescribed regimen to ensure efficacy and reduce the risk of resistance or adverse effects.